Lyme_HLA_Genetic Susceptibility
- Benoit V, Petrich A, Alugupalli K, Marty-Roix R, Moter A, Leong J, Boyartchuk V. Genetic control of the innate immune response to Borrelia hermsii influences the course of relapsing fever in inbred strains of mice. Infection and Immunity 2010; 78: 586-594.
- Iliopoulou B, Guerau-De-Arellano M, Huber B. HLA-DR alleles determine responsiveness to Borrelia burgdorferi antigens in a mouse model of self-perpetuating arthritis. Arthritis Rheum 2009; 12: 3831-3840.
- Cassiani-Ingoni R, Cabral E, Lunemann J, Garza Z, Magnus T, Gelderblom H, Munson P, Marques A, Martin R. Borrelia burgdorferi induces TLR1 and TLR2 in human microglia and peripheral blood monocytes but differentially regulates HLA-Class II expression. J Neuropathol Exp Neurol 2006; 65: 540-548.
- Seward R, Drouin E, Steere A, Costello C. Peptides presented by HLA-DR molecules in synovia of patients with rheumatoid arthritis or antibiotic-refractory Lyme arthritis. Mol Cell Proteomics 2011; 3: M110.00247. doi.1074/mcp.M110.002477.
- Kovalchuka L, Eglite J, Lucenki I, Zalite M, Viksna L, Krumina A. Associations of HLA DR and DQ molecules with Lyme borreliosis in Latvian patients. BMC Research Notes 2012; 5: 438.
- Cabral E, Gelderblom H, Hornung R, Munson P, Martin R, Marques A. Borrelia burgdorferi lipoprotein-mediated TLR2 stimulation causes the down-regulation of TLR5 in human monocytes. Journal of Infectious Diseases 2006; 6: 849-859.
- Strle K, Shin J, Glickstein L, Steere A. Association of a toll-like receptor 1 polymorphism with heightened Th1 inflammatory responses and antibiotic-refractory Lyme arthritis. Arthritis & Rheumatism 2012; 5: 1497-1507.
- Berende A, Oosting M, Kullberg B, Netea M, Joosten L. Activation of innate host defense mechanisms by Borrelia. Eur Cytokine Network 2012; 1: 7-18.
- Drouin E, Seward R, Strle K, McHugh G, Katchar K, Londono D, Yao C, Costello C, Steere A. A novel human autoantigen, endothelial cell growth factor, is a target of T and B cell responses in patients with Lyme disease. Arthritis Rheum 2013; 1: 186-96.
Featured Resources
Shoemaker Protocol™ Quick Start:
The 3 initial steps to determine if mold is affecting you One of the most common questions we hear is, “how do I know if I have mold illness?” Rest assured, if you’re asking this question, you’ve come to the right place.
Lyme Biomarkers Publication Now Available!
Illnesses characterized by chronic fatigue are often defined by symptoms and not by objective biomarkers that support both diagnosis and treatment. Without readily obtained biomarkers, clinical management can be compromised by lack of certainty. This uncert...
Progene DX- Pathway to Certainty Part 1
What you need to know about transcriptomics: Learning a new genomics language; learning new insights on disease
MRA Genomics November 25, 2016
ABSTRACT: Exposure to the microbial growth in Water Damaged Buildings (WDB) can result in a chronic, multi-symptom, multisystem illness, which can last years, termed Chronic Inflammatory Response Syndrome (CIRS). Symptoms of CIRS include but are not limited...
Indoor Environmental Professionals Panel of Surviving Mold CONSENSUS STATEMENT
Medically sound investigation and remediation of water-damaged Buildings in cases of CIRS-WDB Larry Schwartz CIEC, BSME, MBA, Greg Weatherman CMC, Michael Schrantz CIEC, CMI, BPI-BA/EP, Will Spates CIAQP, CIEC, Jeff Charlton, ACIEC, AACIEH, Keith Berndtson...
Related Resources
- CIRS House Hunting Guide
- Certified Practitioner Paula Vetter Presents: "Mold Illness: Surviving and Thriving - A Recovery Manual for Patients and Families Impacted by CIRS"
- 06172014 Structural Brain Abnormalities in Patients with Inflamatory Illness acquired Following Exposure to Water Damaged Buildings A Volumetric MRI Study Using Neuroquant
- 02272013 VIP Corrects CIRS Acquired Following Exposure to Water-Damaged Buildings
- 08152015 Transcriptomic Signatures in Whole Blood of Patients Who Acquire CIRS Following an Exposure to the Marine Toxin Ciguatoxin.
- FAQ Video #4: Exercises and Capillary Hypoperfusion
- 2013 Healthy Home Clinic
- Dr. Mercola Interviews Dr. Shoemaker
- Lyme_Chemokines_Arthritis_CNS_01_19_14
- TREG Lyme Arthritis